首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 基因療法

市場調查報告書

商品編碼

1707942

基因治療市場規模、佔有率、成長分析（按基因類型、按治療類型、按載體類型、按遞送方式、按給藥途徑、按應用、按最終用戶、按地區）- 行業預測，2025 年至 2032 年

Gene Therapy Market Size, Share, and Growth Analysis, By Gene Type, By Therapy type, By Vector type, By Delivery Method, By Route Of Administration, By Application, By End-user, By Region - Industry Forecast 2025-2032

出版日期: 2025年04月08日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球基因治療市場規模價值為 65 億美元，預計將從 2024 年的 77.4 億美元成長到 2032 年的 313.4 億美元，預測期內（2025-2032 年）的複合年成長率為 19.1%。

由於醫療成本不斷上漲、醫療設施日益先進以及報銷選擇不斷增加，全球基因治療市場呈上升趨勢。然而，基因治療藥物的高成本可能在未來幾年內在一定程度上阻礙市場成長。基因治療是一種透過以功能性基因取代缺陷基因來治療多種疾病（包括血液疾病、癌症、慢性病和感染疾病）的創新治療方法。這些是體細胞細胞株治療，針對特定的體細胞來治療愛滋病或帕金森氏症等疾病，以及生殖系基因治療，影響生殖細胞株中的遺傳 DNA。生物載體有助於治療基因的傳遞，包括慢病毒和腺病毒等病毒載體，以及脂質體和質體等非病毒載體。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Krystal Biotech（USA）
CRISPR Therapeutics（Switzerland）
Intellia Therapeutics（USA）
Beam Therapeutics（USA）
Neurogene（USA）
Prime Medicine（USA）
Taysha Gene Therapies（USA）
Verve Therapeutics（USA）
Voyager Therapeutics（USA）
Korro Bio（USA）
Poseida Therapeutics（USA）
MeiraGTx（USA）
enGene（Canada）
Editas Medicine（USA）
uniQure（Netherlands）
Sangamo Therapeutics（USA）
Generation Bio（USA）
Adverum Biotechnologies（USA）
Benitec Biopharma（USA）

結論和建議

簡介目錄

Product Code: SQMIG35H2218

Global Gene Therapy Market size was valued at USD 6.5 billion in 2023 and is poised to grow from USD 7.74 billion in 2024 to USD 31.34 billion by 2032, growing at a CAGR of 19.1% during the forecast period (2025-2032).

The global gene therapy market is on an uptrend, driven by escalating healthcare costs, state-of-the-art healthcare facilities, and reimbursement options. However, the high cost of gene therapies may somewhat hinder market growth in the coming years. Gene therapy is an innovative treatment modality for various diseases, including blood disorders, cancer, chronic illnesses, and infections, by replacing faulty genes with functional ones. It encompasses two primary types: somatic gene therapy, which targets specific body cells to treat conditions like AIDS and Parkinson's, and germline gene therapy, which affects hereditary DNA in reproductive cells. Delivery of therapeutic genes is facilitated by biological vectors, including viral vectors like lentivirus and adenovirus, as well as non-viral options such as liposomes and plasmids.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Therapy Market Segments Analysis

Global Gene Therapy Market is segmented by Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user and region. Based on Gene Type, the market is segmented into Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors and Others. Based on Therapy type, the market is segmented into Gene silencing therapy, Cell replacement therapy, Gene augmentation therapy and Other therapies. Based on Vector type, the market is segmented into Viral vector and Non-Viral Vector. Based on Delivery Method, the market is segmented into Ex-Vivo and In-Vivo. Based on Route Of Administration, the market is segmented into Intravenous Route, Subcutaneous Route and Others. Based on Application, the market is segmented into Oncological Disorders, Cardiovascular Diseases, Infectious Diseases, Hematology, Rare Diseases, Neurological Disorders and Other Diseases. Based on End-user, the market is segmented into Cancer Institutes, Hospitals, Research institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Therapy Market

The global gene therapy market is experiencing significant growth, driven by swift innovations in gene editing technologies like CRISPR-Cas9. These cutting-edge techniques enhance the precision, effectiveness, and safety of genetic modifications, thereby accelerating the clinical development process and expanding treatment options for patients. Furthermore, the use of vector-based methods coupled with improved delivery systems is contributing to the industry's advancement. As a result, the combination of these factors is fostering an environment ripe for breakthroughs in gene therapy, ultimately leading to enhanced therapeutic outcomes and a broader range of solutions for various genetic disorders on a global scale.

Restraints in the Global Gene Therapy Market

The growth of the global gene therapy market is likely to face challenges stemming from various factors, including potential long-term risks, off-target effects, and a host of ethical and safety considerations. These issues could lead to hesitance among the public and regulatory bodies, resulting in a lack of acceptance for new therapies. Such skepticism may deter investment opportunities and impede overall market expansion, as concerns regarding genetic engineering persist. Therefore, overcoming these reservations is essential for fostering confidence in gene therapy developments and ensuring a sustainable trajectory for the industry in the coming years.

Market Trends of the Global Gene Therapy Market

The global gene therapy market is experiencing remarkable growth driven by rapid advancements in genetic research, the rise of innovative treatment methodologies, and an increasing understanding of gene-based therapies. A significant trend is the focus on rare hereditary disorders, as scientists identify genetic defects that underlie these conditions and develop corresponding gene therapies. This shift not only opens new avenues for treatment but also brings hope to patients with previously incurable diseases, fueling demand for targeted and precise therapies. Furthermore, regulatory advancements and increased investment in biotechnology are expected to propel market expansion, solidifying gene therapy's role in modern medicine.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis

Global Gene Therapy Market Size by Gene Type & CAGR (2025-2032)

Market Overview
Antigen
Cytokine
Tumor Suppressor
Suicide
Deficiency
Growth factors
Receptors
Others

Global Gene Therapy Market Size by Therapy type & CAGR (2025-2032)

Market Overview
Gene silencing therapy
Cell replacement therapy
Gene augmentation therapy
Other therapies

Global Gene Therapy Market Size by Vector type & CAGR (2025-2032)

Market Overview
Viral vector
- Retroviral vectors
- AAV Vectors
- Others
Non-Viral Vector
- Oligonucleotide Vectors
- Others

Global Gene Therapy Market Size by Delivery Method & CAGR (2025-2032)

Market Overview
Ex-Vivo
In-Vivo

Global Gene Therapy Market Size by Route Of Administration & CAGR (2025-2032)

Market Overview
Intravenous Route
Subcutaneous Route
Others

Global Gene Therapy Market Size by Application & CAGR (2025-2032)

Market Overview
Oncological Disorders
Cardiovascular Diseases
Infectious Diseases
Hematology
Rare Diseases
Neurological Disorders
Other Diseases

Global Gene Therapy Market Size by End-user & CAGR (2025-2032)

Market Overview
Cancer Institutes
Hospitals
Research institutes
Others

Global Gene Therapy Market Size & CAGR (2025-2032)

North America (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
- US
- Canada
Europe (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Krystal Biotech (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CRISPR Therapeutics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intellia Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beam Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neurogene (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prime Medicine (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taysha Gene Therapies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Verve Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Voyager Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Korro Bio (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Poseida Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MeiraGTx (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
enGene (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Editas Medicine (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
uniQure (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sangamo Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Generation Bio (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adverum Biotechnologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Benitec Biopharma (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments